Pharmacogenetic Perspectives: Genes, Drugs and Disease
- 1 September 1984
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 4 (5) , 959-965
- https://doi.org/10.1002/hep.1840040530
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Assessment of Methods to Identify Sources of Interindividual Pharmacokinetic VariationsClinical Pharmacokinetics, 1983
- Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in manLife Sciences, 1980
- HLA-DR Antigens and Toxic Reaction to Sodium Aurothiomalate and D-Penicillamine in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 1980
- Antipyrine metabolism in the rat by three hepatic monooxygenasesLife Sciences, 1980
- Highly purified cytochrome P-448 and P-450 from rat liver microsomesBiochemical and Biophysical Research Communications, 1975
- The resolution and reconstitution of the liver microsomal hydroxylation systemBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1974
- DIPHENYLHYDANTOIN HALF‐LIFE IN MAN AND ITS INHIBITION BY PHENYLBUTAZONE: THE ROLE OF GENETIC FACTORSActa Medica Scandinavica, 1973
- Pharmacogenetics: Defective Enzymes in Relation to Reactions to DrugsAnnual Review of Medicine, 1972
- Genetic control of dicumarol levels in manJournal of Clinical Investigation, 1968
- Genetic Control of Drug Levels in Man: PhenylbutazoneScience, 1968